Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cgh.2025.08.032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An evaluation of the ACE-V latent fingerprint examination process in the Indonesian National Police.
Sci Justice
September 2025
UCL Department of Security and Crime Science, 35 Tavistock Square, London WC1H 9EZ, United Kingdom; UCL Centre for the Forensic Sciences, 35 Tavistock Square, London WC1H 9EZ, United Kingdom.
This study investigated the implementation of ACE-V (Analysis, Comparison, Evaluation, and Verification) as the standard protocol for fingerprint examination in the Identification Centre of the Indonesian National Police. An online questionnaire-based survey was developed, and 71 Indonesian fingerprint examiners participated. The results showed significant variation in the sequential steps used during the examination process, suggesting the value of exploring more standardized procedures and improving transparency.
View Article and Find Full Text PDFComparing radiologically evident injuries among cisgender and transgender women.
Inj Prev
September 2025
Trauma Imaging Research and Innovation Center, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Background: Despite the high prevalence of violence among transgender and gender-diverse individuals, injury disparities remain understudied and are often attributed to underreporting. To address this limitation, we analysed radiology reports to objectively compare the prevalence and patterns of injuries between transgender women and cisgender women.
Methods: We used the Research Patient Data Registry at a level 1 trauma centre in the USA to identify 263 transgender women and 525 age-matched, race-matched and ethnicity-matched cisgender women.
Modelling US health equity impacts of emicizumab for severe haemophilia A: aggregate distributional cost-effectiveness analysis.
BMJ Open
September 2025
Genentech, South San Francisco, California, USA.
Objectives: Emicizumab is the first bispecific antibody approved for prophylaxis in people with haemophilia A with or without factor VIII inhibitors. Aggregate distributional cost-effectiveness analysis assesses health equity impacts by evaluating how health effects and costs from funding an intervention are distributed among population subgroups. The objective was to evaluate how funding emicizumab for people with severe haemophilia A (PwSHA) impacts population health and health disparities in the USA.
View Article and Find Full Text PDFAre we closing the gender gap in academic oncology? An observational study of gender disparities in participant engagement at the ASCO 2024 annual meeting.
BMJ Open
September 2025
Amsterdam University Medical Centres, Amsterdam, Netherlands
Objective: Despite global efforts, gender disparities in oncology may persist. Understanding these disparities within the context of major conferences can inform strategies to promote gender inclusiveness in the field. This study evaluates the participation of women and men at the American Society of Clinical Oncology (ASCO) 2024 congress, focusing on chairs, speakers and audience questioners.
View Article and Find Full Text PDFEctopic pregnancy epidemiology from 1990 to 2021: A global burden of disease (GBD) analysis of 204 countries and territories.
Eur J Obstet Gynecol Reprod Biol
September 2025
Department of Obstetrics and Gynecology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. Electronic address:
Background: Ectopic pregnancy (EP) represents a leading cause of maternal mortality in early gestation and a significant contributor to future reproductive impairment. Comprehensive understanding of global EP epidemiological patterns and their temporal evolution is crucial for developing holistic strategies to promote health equity and optimize allocation of medical resources worldwide.
Methods: Leveraging Global Burden of Disease (GBD) 2021 data, this investigation systematically examined age-standardized rates (ASRs) of EP incidence, prevalence, mortality, and disability-adjusted life years (DALYs) across 204 countries and 21 regions from 1990 to 2021.